Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | KRSAKorsana Biosciences, Inc.FY2025 · Dec |
|---|---|
| Revenue | $2.07M |
| Revenue, yoy | +3.7% |
| Net income | $3.53M |
| Net income, yoy | −15.4% |
| Net margin | -170.1% |
| Free cash flow | $40.61M |
| FCF margin | — |
| EPS, diluted | $1.11 |
Add another company.